Resource / 13483
unknownUnnamed resource.
Which companies just opened a new clinical trial or site? Bulk feed over NIH ClinicalTrials.gov interventional, industry-sponsored studies, newest-first by registry-posting date (the R&D / commercial-growth signal). Cursor-paginated up to 1000/page, filterable by sponsor, phase, status, condition, intervention type, site state, or since. Rows carry sponsor, phase, status, conditions, enrollment, dates, site count, and the US states sited. Observational registry records, never a prediction.
| State | Network | Scheme | Atomic amount | Asset | payTo / untrusted |
|---|---|---|---|---|---|
| active | eip155:8453 | exact | 25000000 | 0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913 | 0x3873d15CF3209c32aaA8d9AA542164E658567129 |
| active | solana:5eykt4usfv8p8njdtrepy1vzqkqzkvdp | exact | 25000000 | EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v | BdcZbENFdEyEUMqv9pnRMUnn1Yyeyo2dCMbYXbJ3LmaB |
All advertised payment options are stored. Base (`eip155:8453`) is the operational network for ranking and canaries; non-Base options remain visible for transparency.
No probe attempts recorded yet. Coverage runs prioritize never-probed endpoints.
Machine contract
Schemas.
{
"method": "GET",
"queryParams": {
"phase": "PHASE2,PHASE3",
"since": "2026-06-01",
"state": "MA,CA"
},
"type": "http"
}
{
"example": {
"basis": "NIH ClinicalTrials.gov interventional, industry-sponsored studies, one row per study newest-first by first_posted_date. Observational public registry records — a trial appears with a sponsor and a posting date, never a prediction.",
"feed": "clinical-trials",
"page": {
"has_more": true,
"limit": 500,
"next_cursor": "eyJkIjoiMjAyNi0wNi0wMyIsImsiOiJvc2hhOjMxOTAwMTIzNCJ9",
"returned": 500
},
"query": {
"condition": "all",
"intervention_type": "all",
"phase": "all",
"since": "all",
"sponsor": "all",
"state": "all",
"status": "all"
},
"rows": [
{
"as_published_date": "2026-07-24",
"completion_date": "2027-12-31",
"conditions": [
"Pediatric Malignant Solid Tumor",
"Febrile Neutropenia (FN)"
],
"enrollment": 18,
"entity_id": null,
"event_date": "2026-07-24",
"event_key": "nct:NCT07724756",
"first_posted_date": "2026-07-24",
"intervention_types": [
"DRUG"
],
"interventions": [
"Drug: candidate"
],
"nct_id": "NCT07724756",
"overall_status": "RECRUITING",
"phase": "PHASE2",
"primary_completion_date": "2027-06-30",
"site_count": 1,
"site_states": [
"CA"
],
"sponsor_class": "INDUSTRY",
"sponsor_name": "Qilu Pharmaceutical Co., Ltd.",
"start_date": "2026-06-26",
"study_type": "INTERVENTIONAL"
}
]
},
"type": "json"
}